APGE (apogeetherapeutics.com) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan Apogee Therapeutics Inc (APGE)

Apogee Therapeutics (APGE) is actively collaborating with research centers to accelerate clinical trials for new drugs. The company has bolstered its staff with leading immunologists, while stable capital prevents talent attrition. This price trend reflected below on GURU.Markets, where the indicator stands at 8.47, confirms the company's momentum. Business revenues will rely on the commercial launch of long-acting antibodies for the therapy of skin inflammation.

APGE Apogee Corp: Nilai Pasar marang Nilai Buku ing interval 21.02.2024 - 19.09.2026

Rincian metrik keuangan lan pasar Apogee Therapeutics Inc (APGE)

- rega lan prakiraan konsensus rega:
Rega saham Apogee Therapeutics|APGE - Rata-rata rega prakiraan
- data kapitalisasi pasar:
Nilai pasar Apogee Pharma|APGE - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Apogee Therapeutics|APGE - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku apogeetherapeutics.com|APGE - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Apogee Therapeutics|APGE - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Apogee Pharma|APGE - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Apogee Pharma|APGE - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Apogee Therapeutics
Analisis wiwitan perusahaan:Apogee Therapeutics - APGE
Produk asli Apogee Pharma

For Apogee Therapeutics (APGE), the gap between market expectations and net asset value reflects the potential of future patents against the backdrop of colossal FDA certification costs. Analyzing the market-to-book ratio allows for determining the premium paid for intellectual capital by comparing current capitalization with the company's actual balance sheet to assess the business's investment attractiveness.

Pesaing utama

Rasio Kapitalisasi Pasar marang Nilai Buku KRYS|ARQT (arcutis.com) - Koefisien Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Vericel VCEL|Kapitalisasi Pasar marang Aset Bersih Oruka Therapeutics, Inc.|Sanara MedTech Inc. (SMTI) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku dbv-technologies.com (DBVT)|Rasio Kapitalisasi Pasar marang Nilai Buku SLSN (Solesence)|Journey Medical Corp - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Forte Biosciences (FBRX)|EMPG: Nilai Pasar marang Nilai Buku|SLGL (Sol-Gel) - Rasio Nilai Pasar marang Nilai Buku|AXIL Brands (AXIL) - Rasio Kapitalisasi marang Aset Bersih|MDCX (Medicus Pharma Ltd.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku Verrica (VRCA)|Hoth Therapeutics, Inc. (HOTH) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku BFRI (biofrontera-us.com)|Rasio Nilai Pasar marang Nilai Buku VYNE|Sonoma Pharmaceuticals Inc. - Kapitalisasi Pasar marang Nilai Buku|Quoin Pharma - Rasio Nilai Pasar marang Nilai Buku|AZTR - Rasio Kapitalisasi Pasar marang Nilai Buku|Dermata Therapeutics, Inc. - Rasio Kapitalisasi Pasar marang Nilai Buku|ELAB (Elevai Labs Inc) - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Revance Therapeutics, Inc (RVNC)